Reports
Sale
Global Glycobiology Market Size, Share, Forecast: By Product: Enzymes, Instruments, Reagents, Kits; By Application: Drug Discovery and Development, Disease Diagnostics, Virology, Cell Biology, Oncology, Others; By End User: Research Institutes, Diagnostic Centers, Hospitals, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Glycobiology Market Outlook
The global glycobiology market size was valued at USD 1.73 billion in 2023, driven by the elevating recognition of the existence of glycans in biology across the globe. The market is anticipated to grow at a CAGR of 15.2% during the forecast period of 2024-2032 to achieve a value of USD 6.17 billion by 2032.
Glycobiology: Introduction
Glycobiology is an area of study in which carbohydrates are studied that are also known as glycans. The carbohydrates and their role in different biological processes are studied in glycobiology. It is the study about the structure, functionality, and communications of glycan with lipids and other molecules present in living organisms. Carbohydrates play an important role in several biological processes such as cell-to-cell interaction, disease progression, and many others. In Glycobiology the role of carbohydrates in these processes is studies and how they can be used for treatments in various conditions as well.
Global Glycobiology Market Analysis
The primary trend aiding the global glycobiology market growth is the increasing focus of researchers on exploring the potential of glycans for treatment applications in healthcare industry. The therapeutic applications of glycans may include glycoconjugate vaccines, in order to treat diseases. The increasing focus on exploring therapeutic applications of glycans is a major trend in the market.
Additionally, the use of mass spectrometry and high-performance liquid chromatography has increased in order to characterize glycome of biological fluids, tissues, and cells. Glycobiology is slowly drifting towards exploring the functional efficiency of glycans from just studying the glycan structures.
Glycobiology plays a significant role in the development of personalized medicine, as glycans are involved in disease progression, drug response, and patient stratification. The increasing focus on developing personalized medicine is driving the demand for glycobiology research and diagnostic tools in the market. The increasing research and development activities in the field of glycobiology which is driven by the escalating comprehension of the role of glycans in various biological processes. This trend is leading to the discovery of new glycan-based biomarkers and therapeutic targets.
Global Glycobiology Market Segmentations
Market Breakup by Product
- Enzymes
- Instruments
- Reagents
- Kits
Market Breakup by Application
- Drug Discovery and Development
- Disease Diagnostics
- Virology
- Cell Biology
- Oncology
- Others
Market Breakup by End User
- Research Institutes
- Diagnostic Centers
- Hospitals
- Clinical Laboratories
- Pharmaceutical and Biotechnology Companies
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Glycobiology Market Overview
The increasing interest in studies of glycans (carbohydrates) along with their benefits in biological systems is a major factor aiding the global glycobiology market development. The study of glycans has gathered comparatively more attention in past few years. The market for research of glycobiology and its applications is encountering stable growth and is expected to continue growing in the coming years.
Additionally, the increasing understanding of glycans and its importance in various biological processes and diseases is a major factor driving the glycobiology market expansion. There is a vital role that glycans play in cell-cell communication, immune response, protein folding and stability, and several other biological functions. As researchers reveal more information about the complex interactions between glycans and proteins, there is a growing demand for tools, technologies, and expertise in glycobiology.
In conclusion, the glycobiology market is witnessing growth due to the elevating recognition of the existence of glycans in biology and disease, the demand for equipment and technologies to study and alter glycans, and the potential uses of glycobiology in healthcare and pharmaceutical industries. The market is expected to continue expanding as research in glycobiology improves and more applications are found.
Glycobiology Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Merck KGaA
- Thermo Fisher Scientific Inc.
- Shimadzu Corporation
- Takara Bio Inc.
- Promega Corporation
- Danaher Corporation
- AMS Bio
- Sumitomo Bakelite Co. Ltd.
- Dextra Laboratories Ltd.
- RayBiotech, Inc.
- Waters Corporation
- Glycotope GmbH
- New England Biolabs, Inc.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Glycobiology Market Overview
3.1 Global Glycobiology Market Historical Value (2017-2023)
3.2 Global Glycobiology Market Forecast Value (2024-2032)
4 Global Glycobiology Market Landscape
4.1 Global Glycobiology Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Glycobiology Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Application
5 Global Glycobiology Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Glycobiology Market Segmentation
6.1 Global Glycobiology Market by Product
6.1.1 Market Overview
6.1.2 Enzymes
6.1.3 Instruments
6.1.4 Reagents
6.1.5 Kits
6.2 Global Glycobiology Market by Application
6.2.1 Market Overview
6.2.2 Drug Discovery and Development
6.2.3 Disease Diagnostics
6.2.4 Virology
6.2.5 Cell Biology
6.2.6 Oncology
6.2.7 Others
6.3 Global Glycobiology Market by End User
6.3.1 Market Overview
6.3.2 Research Institutes
6.3.3 Diagnostic Centers
6.3.4 Hospitals
6.3.5 Clinical Laboratories
6.3.6 Pharmaceutical and Biotechnology Companies
6.3.7 Others
6.4 Global Glycobiology Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Glycobiology Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Glycobiology Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Glycobiology Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Glycobiology Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Glycobiology Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Merck KGaA
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Thermo Fisher Scientific Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Shimadzu Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Takara Bio Inc.
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Promega Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Danaher Corporation
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 AMS Bio
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Sumitomo Bakelite Co. Ltd.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Dextra Laboratories Ltd.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 RayBiotech, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Waters Corporation
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Glycotope GmbH
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 New England Biolabs, Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Glycobiology Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 1.73 billion in 2023 driven by the increasing research and development activities in the field of glycobiology.
The market is anticipated to grow at a CAGR of 15.2% during the forecast period of 2024-2032, likely to achieve a value of USD 6.17 billion by 2032.
The rising demand for tools and technologies to study and manipulate glycans is a major driver contributing to the market growth.
The increasing focus of researchers on exploring the potential of glycans for treatment applications is major key trends in the glycobiology market.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
The different types of products in the market are enzymes, instruments, reagents, and kits.
Glycobiology finds wide application in discovery and development, disease diagnostics, virology, cell biology, oncology, among others.
The end users in the market are research institutes diagnostic centers, hospitals, clinical laboratories, pharmaceutical and biotechnology companies, among others.
Key players involved in the market are Merck KGaA, Thermo Fisher Scientific Inc., Shimadzu Corporation, Takara Bio Inc., Promega Corporation, AMS Bio, Sumitomo Bakelite Co. Ltd., Dextra Laboratories Ltd., RayBiotech, Inc., Waters Corporation, Glycotope GmbH, New England Biolabs, Inc., and Danaher Corporation.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER